In February 2024, the FDA granted breakthrough therapy designation to NVL-520 as a treatment for patients with ROS1-positive metastatic non–small cell lung cancer (NSCLC) who received prior treatment ...

An AI foundation model capable of predicting gene activity across many different human cell types may expedite research for ...

The melding of visual information (microscopic and X-ray images, CT and MRI scans, for example) with text (exam notes, ...

A study published today in the journal Nature by researchers at Columbia University described a new medical AI model that ...

A new artificial intelligence tool combines data from medical images with text ... image or scan show signs of cancer?) rather than for prognosis (what is this person's likely clinical outcome, and ...

7, 2025 /PRNewswire/ — GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab, Bristol Myers Squibb’s ...

This process is referred to as cell ... large number of original publications and reviews that deal with immunotherapy advocate for more imaging, especially more specific imaging of receptors, ...

There are two main types of lung cancer: small cell and non-small cell lung cancer (NSCLC). Non-small cell lung cancer, the more common and slow-growing of the two, consists of different subtypes, ...

A variant of PCSK9, a gene involved in raising cholesterol, may spur metastasis. An approved antibody might stop it.

I also have a recent cancer diagnosis. I have $900,000 in retirement ... I own my home outright, which I am leaving totally to one charity. I have a large bank as trustee, and it will take ...

The past year at Fred Hutch Cancer Center has been marked by exceptional achievements and inspiring moments. We’ve collected pictures and stories throughout 2024 that highlight our commitment to ...